Sequenom VP Inflated Down Syndrome Test: SEC

Law360, New York (June 3, 2010, 4:21 PM EDT) -- The U.S. Securities and Exchange Commission has filed a lawsuit alleging a former executive of Sequenom Inc. falsely claimed that a prenatal test the company made could predict with 100 percent accuracy whether a fetus had Down syndrome, holding her responsible for the stock price plummet that occurred when data was revealed to be untrue.

In a complaint filed Wednesday in the U.S. District Court for the Southern District of California, the SEC accused former Sequenom Senior Vice President of Research and Development Elizabeth Dragon of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.